Purpose: Endoscopic submucosal dissection has recently been practiced on a differentiated type of early gastric cancer. However, there is no clear evidence for endoscopic treatments of signet ring cell carcinoma. The aim of this study is to identify the predictive clinicopathological factors for lymph node metastasis in signet ring cell carcinoma for assisting endoscopic submucosal dissection trials. Materials and Methods: A total of 186 patients with early signet ring cell carcinoma who underwent radical curative gastrectomy between January 2001 and September 2009 were enrolled in this study. Retrospective reviews of their medical records are being conducted. Several clinicopathologic factors were being investigated in order to identify predictive factors for lymph nodes metastasis: age, gender, tumor size, type of operation, tumor location, gross type, ulceration, Lauren's classification, depth of invasion, and lymphatic invasion. Results: The lymph node metastasis rate for signet ring cell carcinoma was 4.3% (n=8). Of the 186 lesions with early signet ring cell carcinoma, 91 (48.9%) tumors were larger than 15 mm in size and 40 (21.5%) showed submucosal invasions in the resection specimens. In multivariate analysis, only the lymphatic invasion (P<0.0001) showed an association with lymph node metastasis. To evaluate cutoff values for tumor sizes in the presence of lymph node metastasis, early signet ring cell carcinomas with lymphatic invasions were excluded. In the absence of lymphatic invasion, mucosal cancer with tumor sizes <15 mm had no lymph node metastasis. Conclusions: Endoscopic submucosal dissection can be performed on patients with early signet ring cell carcinoma limited to the mucosa and less than 15 mm.
Introduction
Endoscopic submucosal dissection (ESD) has been widely accepted as an alternative treatment for early gastric cancer (EGC). 1 Due to the higher risk of lymph node metastasis (LNM) in undifferentiated EGC, application of ESD has been limited to EGC of well or moderately differentiated histology smaller than 30 mm in diameter and confined to the mucosa without ulceration. 2, 3 According to the Japanese Gastric Cancer Association, undifferentiated gastric carcinoma includes poorly differentiated adenocarcinoma and signet ring cell carcinoma (SRC). 4 However, a recent study reported that undifferentiated EGC smaller than 15 mm and confined to mucosa or with minimal submucosal infiltration (≤500 μm) had no LNM, 5 suggesting that patients with undifferentiated EGC under specific conditions could be considered as candidates for ESD. In addition, EGC with the histological features of SRC is a distinct biologic manifestation of gastric cancer. 6 The lower rate of LNM and favorable prognosis of early SRC could be considered for curative ESD. 7 However, there is little evidence for effectiveness of this procedure in clinical practice.
Thus, we conducted this study in order to determine the factors related to LNM in early SRC, and to guide the individual application of ESD in a suitable subgroup of patients with early SRC.
Materials and Methods was used in performance of statistical analysis. To identify risk factors predictive of LNM, the data were analyzed using the chisquared test. Multivariate logistic regression analysis was performed for evaluation of independent risk factors affecting LNM. A Pvalue of less than 0.05 was considered statistically significant.
Patients

Statistical analysis
Results
Clinical features of patients
Of the 186 patients with early SRC who had undergone radical According to submucosal layer category, there were 14 (7.5%), 13 (7.0%), and 13 (7.0%) SM 1, SM 2, and SM 3 lesions, respectively.
And seven patients (3.8%) had lymphatic involvement. Among them, four patients had submucosal invasion. A summary of the baseline characteristics of enrolled patients is shown in Table 1 .
Risk Factors for lymph node metastasis by univa riate and multivariate analysis
Individual risk factors for LNM were investigated in early SRC.
The rate of LNM was 4.3% (n=8). In univariate anlaysis, LNM
showed a strongly association with lymphatic involvement (P ＜0.0001). Tumor size, ulceration and submucosal invasion did not show a significant association with LNM (Table 2) .
Multivariate analyses were performed in order to investigate the relationship with depth of invasion, lymphatic invasion, and ulceration. In multivariate analysis, the independent risk factors for LNM was lymphatic involvement (odds ratio: 58.333, 95% confidence interval: 9.6~351.2) ( Table 3 ).
Cutoff tumor size for endoscopic treatment
To evaluate cutoff values for tumor size in the presence of LNM, tumor size and submucosal invasion were stratified. After exclusion of early SRC with lymphatic invasion, a total of four patients were analyzed. In the absence of lymphatic invasion, mucosal cancer with tumor size ＜15 mm had no LNM. Values are presented as number (%). Chai-squre test was used. SM = submucosal invasion depth. (Table 4) .
Discussion
As a result of advances in diagnostic technology, including both the radiologic and endoscopic modalities, the incidence of EGC has increased. Due to the higher rate of LNM in the undifferentiated histologic type, the accepted indications for ESD are limited to differentiated EGC. Recently, according to Japanese gastric cancer treatment guidelines 2010 (ver. 3), 8 ESD for undifferentiated type tumors clinically diagnosed as T1a (mucosa confined) and less than 2 cm in diameter without ulceration is regarded as an investigational treatment (expanded indication). However, evidence regarding the curability of ESD under the expanded criteria remains insufficient, 9 and should be prospectively evaluated in appropriate clinical research settings. Therefore, in this study, we attempted to establish a criterion for expansion of the possibility of using ESD for treatment.
Early SRC differs significantly from non-SRC, in terms of the depth of invasion, and LNM. 10 The prognosis of early SRC is more favorable than that of non-SRC. 7, 10, 11 One study reported a strong association of poorly differentiated EGC with the presence of ulcer, submucosal invasion, and lymphovascular invasion, compared with early SRC. This means that poorly differentiated EGC is more complicated than early SRC when considering endoscopic treatment. 12 Thus, we sought to expand the use of ESD to early SRC by retrospective examination to determine predictive factors of LNM.
Previous studies have reported that tumor size, lymphatic invasion, and depth of invasion were significant factors for prediction of LNM. 13, 14 A recent study 12 reported that early SRC with mucosal invasion, size ＜15 mm, and no lymphatic invasion had no LNM.
Another study 15, 16 reported that early SRC with mucosal invasion, size ≤2 cm, and no lymphatic invasion had no LNM. In our study, in univariate and multivariate analysis, LNM of early SRC showed a strong association with lymphatic invasion. We also analyzed LNM in terms of tumor size and depth of invasion. After exclusion of cases of early SRC with lymphatic involvement, four patients were analyzed. LNM was found only in cases in which the tumor size was greater than 15 mm. In our study, there was no significant finding between depth of invasion and LNM. However, there was a positive tendency for LNM in patients with submucosal invasion (P=0.067). This may be due to the small number of cases.
Based on the findings of our study, we supposed that ESD could be possible in early SRC confined to mucosa, less than 15 mm in size. Actually, in our center, five cases of early SRCs treated by ESD were technically feasible during the follow-up period. Similarly, one study 17 reported that complete endoscopic resection was possible in the majority of tumors ≤20 mm in size, as well as in intramucosal carcinomas, and no recurrence and no metastasis occurred after ESD during a median follow-up period of 13 months.
There are several limitations in the design of this study. One potential limitation of our study is that it was conducted as a single center retrospective study with a small number of cases. However, all patients who underwent radical gastrectomy were reviewed and histologic slides were re-examined by one pathologist during the (102/103) of en bloc and curative resection and yielded good longterm outcomes. 18 Use of ESD for undifferentiated EGC has only begun recently, therefore, the precise usefulness of ESD for early SRC remains to be evaluated prospectively in a large scale trial.
Our results were similar to those of previous studies and outcomes of ESD were favorable in actual clinical settings. Therefore, although there is little information on long-term follow-up, ESD of early SRC may be reasonable under specific tumor conditions.
Conduct of further studies is needed in order to validate expanded indications for ESD in patients with early SRCs.
